1. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials. Issue 10340 (28th May 2022) Authors: D'Haens, Geert; Panaccione, Remo; Baert, Filip; Bossuyt, Peter; Colombel, Jean-Frederic; Danese, Silvio; Dubinsky, Marla; Feagan, Brian G; Hisamatsu, Tadakazu; Lim, Allen; Lindsay, James O; Loftus, Edward V; Panés, Julian; Peyrin-Biroulet, Laurent; Ran, Zhihua; Rubin, David T; Sandborn, William J... Journal: Lancet Issue: Volume 399:Issue 10340(2022) Page Start: 2015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Issue 10340 (28th May 2022) Authors: Ferrante, Marc; Panaccione, Remo; Baert, Filip; Bossuyt, Peter; Colombel, Jean-Frederic; Danese, Silvio; Dubinsky, Marla; Feagan, Brian G; Hisamatsu, Tadakazu; Lim, Allen; Lindsay, James O; Loftus, Edward V; Panés, Julián; Peyrin-Biroulet, Laurent; Ran, Zhihua; Rubin, David T; Sandborn, William J... Journal: Lancet Issue: Volume 399:Issue 10340(2022) Page Start: 2031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S0648 Clinically Adjusted vs Therapeutic Drug Monitoring Dosing Regimens With Adalimumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the SERENE-CD Maintenance Study. (October 2020) Authors: Danese, Silvio; Sandborn, William J.; Loftus, Edward V.; Hanauer, Stephen; Schreiber, Stefan; Peyrin-Biroulet, Laurent; Panaccione, Remo; Panés, Julian; Baert, Filip; Colombel, Jean-Frederic; Ferrante, Marc; Louis, Edouard; Armuzzi, Alessandro; Goteti, Venkata Sasikiran; Mostafa, Nael; Doan, Thao... Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1 Page Start: S325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S38 On-Body Injector Administration of Risankizumab for Treatment of Moderate-to-Severe Crohn's Disease: Data From the Fortify Open-Label Longitudinal Real-Life Handling Substudy. (December 2022) Authors: Loftus, Edward; Griffith, Jenny; Neimark, Ezequiel; Song, Alexandra; Wallace, Kori; Nannapaneni, Sujani; Zhou, Ji; Andresen, Rachel; Kligys, Kristina; Liao, Xiaomei; Dubinsky, Marla Journal: American journal of gastroenterology Issue: Volume 117(2022)Supplement 2022 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S695 Risankizumab Induces Early Clinical Remission and Response in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies. (October 2021) Authors: Schreiber, Stefan; Ferrante, Marc; Panaccione, Remo; Colombel, Jean-Frederic; Hisamatsu, Tadakazu; Lim, Allen; Lindsay, James; Rubin, David T.; Sandborn, William; Neimark, Ezequiel; Song, Alexandra; Liao, Xiaomei; Feng, Tian; Berg, Sofie; Wallace, Kori; D'Haens, Geert Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S714 52-Week Risankizumab Subcutaneous Maintenance Dosing Is Efficacious and Well Tolerated in Patients With Moderate to Severe Crohn's Disease Who Had Delayed Response to 12-Weeks IV Risankizumab Induction. (October 2022) Authors: D'Haens, Geert; Panaccione, Remo; Panés, Julian; Hisamatsu, Tadakazu; Bossuyt, Peter; Danese, Silvio; Neimark, Ezequiel; Song, Alexandra; Liao, Xiaomei; Wallace, Kori; Zambrano, Javier; Duan, W Rachel; Kligys, Kristina Other Names: Dubinsky Marla presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S748 Risankizumab Results in Improvements in Disease Activity Scores in Patients With Crohn's Disease: Post-Hoc Analysis of the Phase 3 Induction and Maintenance Studies. (October 2022) Authors: Ferrante, Marc; Colombel, Jean-Frederic; Kligys, Kristina; Van Haaren, Stijn; Song, Alexandra; Neimark, Ezequiel; Zambrano, Javier; Liao, Xiaomei; Dubinsky, Marla Other Names: Loftus Edward V. presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S754 Risankizumab as Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease Who Failed 1 vs >1 Prior Biologic Treatment: Results From the MOTIVATE Study. (October 2021) Authors: Panaccione, Remo; Schreiber, Stefan; Peyrin-Biroulet, Laurent; Loftus, Edward V.; Dubinsky, Marla; Ferrante, Marc; Song, Alexandra; Huang, Bidan; Liao, Xiaomei; Berg, Sofie; Duan, Weijiang R; Wallace, Kori; Feagan, Brian Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies. (October 2021) Authors: Bossuyt, Peter; Ferrante, Marc; Baert, Filip; Danese, Silvio; Feagan, Brian; Loftus, Edward V.; Panés, Julian; Peyrin-Biroulet, Laurent; Ran, Zhihua; Armuzzi, Alessandro; D'Haens, Geert; Song, Alexandra; Neimark, Ezequiel; Liao, Xiaomei; Zhou, Qian; Berg, Sofie; Wallace, Kori; Panaccione, Remo Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S808 Mechanisms of Non-Response to Adalimumab on Inflammatory Bowel Disease: Peripheral Proteomic and Transcriptomic Profiling from the SERENE-CD and SERENE-UC Studies. (October 2021) Authors: Panés, Julian; Verstockt, Bram; Pivorunas, Valerie; Butler, James; Mahi, Naim; Ruzek, Melanie; Sornasse, Thierry; Fann, James; Hong, Feng; Cao, Xiaohong; Smaoui, Nizar; Davis, Justin Wade; Kalabic, Jasmina; Song, Alexandra; Guay, Heath; Salas, Azucena; Kennedy, Nick; Ahmad, Tariq; Vermeire, Severine Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗